A First-In-Human Study With a Single Ascending Dose of UCB7858 in Healthy Volunteers

NCT02879877 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
78
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

UCB Biopharma S.P.R.L.